JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.
Shiga toxin recognizes a galactose-al-^-galactose terminal glycolipid, globotriaosylceramide (Gb3), in sensitive mammalian cells and is translocated by endocytosis to the cytoplasm, where it blocks protein synthesis. To determine if Gb3 is both required and sufficient for toxicity, Gb3 content in cells was altered by blocking key biosynthetic or degradative path enzymes with specific inhibitors. The resulting decrease or increase in cellular Gb3 was associated with a decrease or increase in binding of and response to Shiga toxin. Toxin-resistant Gb3-deficient variants of sensitive cells fused with liposomes containing Gb3 but not globotetraosylceramide (Gb4) became susceptible, whereas fusion of Gb3 liposomes to naturally resistant Gb3-deficient CHO cells increased toxin binding but not cytotoxicity. These data demonstrate that Gb3 is required, but not sufficient, for the action of Shiga toxin and suggest the existence of a toxin translocation mechanism linked to surface glycolipids that is not expressed in CHO cells.
The Shiga family of toxins is linked to the pathogenesis of hemolytic uremic syndrome, which complicates diarrheal disease due to cytotoxin-producing Shigella dysenteriae type 1 or certain serotypes of Escherichia coli associated with hemorrhagic colitis [1] . These toxins are heterodimeric proteins that comprise an enzymatically active A subunit that irreversibly inhibits protein synthesis by mammalian ribosomes [2] and multiple B subunits that recognize neutral glycolipids on the target cell surface. Shiga toxin-binding glycolipids all contain a terminal Gal-a 1 -M-Gal disaccharide, such as globotriaosylceramide (Gb3 or Gal-a 1-^4-Gal-iSl-^4-Glc-i(31-ceramide) [3] [4] [5] . Because their biochemical target is the ribosome, Shiga family toxins must be internalized by cells to exert toxicity. Internalization proceeds by receptor-mediated endocytosis [6] from clathrin-coated regions of the plasma membrane [7] .
The evidence that Gal-a 1-^4-Gal terminal glycolipids serve as the receptors for internalization of Shiga toxin consists of three observations: holotoxin or purified toxin B subunit binds specifically to purified Gb3 in vitro and to Gb3 extracted from toxin-sensitive cells and tissues [3] [4] [5] ; cytotoxicity in tissue culture lines and cloned HeLa cells correlates with the cell content of Gb3 [8] ; and enterotoxicity (intestinal fluid secretion) in rabbit small bowel loops correlates with the appearance of Gb3 in the microvillus membrane at day 16 of postnatal life [9, 10] . In piglets, tissue localization of intravenously injected E. coli Shiga-like toxin (SLT)-I, which has a B subunit identical to that of Shiga toxin, is proportional to tissue content of Gb3 [11] . However, lesions in this species occur primarily in brain and not necessarily in tissues to which toxin binds at higher levels, suggesting that some but not all Gb3 binding sites are functional receptors. The only direct evidence that Gb3 is a required receptor is the report that Shiga toxin-resistant Daudi cells become sensitive after incubation with Gb3-containing liposomes [12] .
The experiments presented here were designed to more fully investigate the role of and requirement for Gb3 in the toxic effects of Shiga toxin by examining the consequence of altering, by various means, the Gb3 content in sensitive and resistant cells.
Culture Collection, Rockville, MD). HeLa and Vero cells were maintained in McCoy's 5A modified medium supplemented with \07c fetal bovine serum (FBS), 100 units/mL penicillin, and 100 Mg/mL streptomycin (Life Technologies GIBCO BRL, Gaithersburg, MD). CHO cells were grown in F12 nutrient mixture containing proline with FBS and antibiotics (Life Technologies Gibco BRL). To select toxin-resistant lines, parent strain HeLa cells in logarithmic phase were exposed overnight at 370C to 0.1 iJLg/mL Shiga toxin in medium, washed, and then allowed to grow to confluence in fresh medium. The surviving cells, designated T1, were sequentially passaged four more times (T2-T5) in increasing concentrations of toxin, up to 10 ng/mL for 7 days. T5 cells were resistant to overnight incubation with 10 jug/mL toxin.
Cytotoxicit y and amino acid uptake assays. Cytotoxicity was assessed either by assaying overnight detachment of cells from the monolayer as previously reported [ 15] Toxin binding. 125I-labeled Shiga toxin was serially diluted in medium at 40C, and 30 jliL of each dilution was applied in triplicate to cells grown in 96-well microtiter plates chilled to 40C. After 1 h at 40C, monolayers were washed three times with medium and twice with PBS and then solubilized in 100 /jlL of 0.1 M KOH; radioactivity was determined. Capacity and affinity of binding were calculated by Scatchard analysis [8] .
Glycolipid content of cells. To determine glycolipid content, monolayers were washed in PBS, scraped, and extracted in 2 mL of methanol at 550C for 15 min. A Folch partition was established by addition of 4 mL of chloroform and 1.5 mL of HjO [16] . Lower-phase lipids were applied to a Unisil column (Clarkson Chemical, Williamsport, PA) and the neutral glycolipids, eluted with acetone:methanol (9:1, vol/vol), were hydrolyzed with methanolic NaOH, subjected to a Folch partition, and benzoylated with 10^ benzoyl chloride in pyridine [17] . Samples were dissolved in carbon tetrachloride and injected onto a pellicular Zipax column (Du Pont, Wilmington, DE) for separation by high-performance liquid chromatography (HPLC; Waters, Milford, CT) with a linear 2%-42% gradient of 467c dioxane in hexane diluted into hexane at a flow rate of 2 mL/min over 13 min [10] . All HPLC grade solvents were from Fisher Scientific (Pittsburgh). Eluted peaks were detected by absorption at 230 nm. Protein content of the scrapings was determined with a protein assay reagent (BioRad Laboratories, Richmond, CA).
Surface labeling of HeLa cells. Exposed galactose residues were labeled by oxidation with galactose oxidase followed by reduction with tritiated sodium borohydride [3H]NaBH4; Du Pont NEN Research Products) [18] . Monolayers (5 X 107 cells)
were grown in 150-mm diameter tissue culture plates and prereduced by incubation with NaBH4 (1.75 mg in 5 mL of PBS) for 5 min at 250C, washed twice with serum-free medium, and harvested by scraping and centrifugation at 1000 rpm for 5 min. Cells were incubated with 10 units of galactose oxidase in 100
IxL of serum-free medium for 3 h at 370C, washed twice with 10 mL of 0.15 M PBS, pH 7.2, and centrifuged as above; 1 mCi of [3H]NaBH4 in 50 i*L of PBS was added to each pellet for 30 min at 250C with shaking. After five washes with 10 mL of PBS, neutral glycolipids were isolated and separated by quantitative HPLC over 40 min at a flow rate of 1 mL/min, as described above. Glycolipid content was measured by integrating the area under the curve. Radioactivity associated with each peak was measured simultaneously using a flow-through scintillation counter attached to the HPLC column system. Specific activity of each peak was calculated.
Preparation of Gb3-containing liposomes and fusion conditions. A mixture of 500 ng of Gb3, 500 ng of phosphatidylethanolamine, 500 /ig of phosphatidylserine, and 75 ixg of palmitic acid (all from Matreya, Pleasant Gap, PA) in CHCI3 was dried under nitrogen, resuspended in 1 mL of PBS, and sonicated to clarity (450 Sonifier [power setting 3, 50^ cycle, 5 min]; Branson Ultrasonics, Danbury, CT). For fusion experiments, CHO or HeLa T5 cells were trypsinized, washed, and resuspended in medium at 2 X 107 cells/mL. Cells (100 juL) were mixed with 100 /xL of PBS or the liposome preparation and rotated at 370C for 2 h, when 500 juL of 50^o polyethylene glycol (PEG; Life Technologies GIBCO BRL) was added. After a further 10 min of rotation, cells were washed twice with 10 mL of medium and suspended in medium at 5 X 105 cells/mL. Cell suspension (100 /jlL) was dispensed into 96-well microtiter plates and incubated overnight at 370C. Binding of 125I-labeled Shiga toxin was measured and, in companion cells, cytotoxicity was assayed by the [3H]leucine incorporation method.
To optimize fusion conditions and to assess fusion in these experiments, liposomes were prepared in the presence of 100 mM 5(6)-carboxyfluorescein (Sigma, St. Louis) [19] . Free dye was removed by column chromatography (Sephadex G-25; Pharmacia LKB Biotechnology, Piscataway, NJ), and liposomal fusion was monitored by fluorescence microscopy. 5(6)-carboxyfluorescein is self-quenched at high concentration, as in liposomes, but fluoresces when diluted into the cytoplasm after fusion.
Effects of 1,5-dideoxy-l,5-imino-D-galactitol (DIG). HeLa T5 cells were incubated for 6 days with daily changes of medium containing 10 nM DIG, a competitive inhibitor of lysosomal a-galactosidase (provided by B. Ganem, Cornell University, Ithaca, NY) [20, 21] . On day 6, treated cells were dispensed into 96-well microtiter plates and incubated overnight in medium with 10 /iM DIG. The following day, leucine incorporation, amino acid uptake, and glycolipid content were measured as described above.
Effects of dj-threo-1-phenyl-2-decanoylimino-3-morpholino- 1- propanol HCl (PDMP Gb4 is more surface-exposed and more readily labeled than Gb3.
To determine the basis for these differences in glycolipid content, we assayed the galactosyltransferase and a-galactosidase enzyme activities involved in biosynthesis and degradation of Gb3. Galactosyltransferase directly correlated with both Gb3 content and sensitivity to Shiga toxin (figure 1).
No difference was found in cellular a-galactosidase activity between parent CCL2 cells and resistant lines derived from them (data not shown). Galactosyltransferase activity was also greater in the more sensitive ATCC HeLa 229 line not shown). These conditions were used for all Binding of 125I-labeled Shiga toxin to toxin-res CHO cells preincubated with liposomes loaded Gb4 is shown in figure 3A and B, respectively. To determine if the failure to affect CHO cell susceptibility to Shiga toxin when Gb3 was fused into the cell mem- Table 2 . Relationship between cytotoxicity assays and amino acid uptake. cell types incorporated similar amounts of labeled leucine into protein in either the presence or absence of PDMP and both showed high-level toxin resistance after growth in the presence of PDMP ( figure 5 A and B, respectively) . To determine if this resistance was due solely to the reduced Gb3 content, we attempted to add back Gb3 by liposomal fusion to PDMP-treated Vero cells. In the absence of PDMP, liposomal fusion had no effect on cytotoxicity, whereas insertion of Gb3, but not Gb4, reversed the effect of the inhibitor ( figure 6A and B) .
Discussion
These studies demonstrate that Gb3, a neutral glycolipid expressed at the cell surface, is necessary but not sufficient to confer sensitivity of mammalian cells to Shiga toxin. The data confirm and extend prior observations correlating Gb3 content and sensitivity to Shiga toxin using resistant HeLa cell lines selected by passage of sensitive cells in increasing concentrations of toxin. However, we observed a discordance between the percentage change in Gb3 content and cytotoxicity. For example, although the maximum observed difference between the parent and resistant lines in toxinbinding capacity and sensitivity to toxin was 600-fold and at least 10 orders of magnitude, respectively, sensitive parent
HeLa cells contained only five times as much Gb3 as the highly resistant T5 cells. We surface-labeled exposed glyco- 
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Gb3 were to concentrate in clathrin-coated regions of membrane where Shiga toxin uptake occurs [7] . In this way, small changes in the total receptor content might mediate the greater observed changes in the biologic effects of the toxin.
Alternatively, if there is a separate translocation mechanism with which Gb3-bound toxin must interact, increased membrane Gb3 content could also enhance the chance of this occurring, again resulting in a sharp increase in toxicity a receptor content slowly increased. Thus, when the content Gb3 is low and dispersed, much of the surface Gb3 may b unable to function as a receptor. Gb3 transferase activity, but the more sensitive HeLa 229 cells also contained significantly higher levels of activity than did HeLa CCL2 cells. In addition to this greater synthetic enzyme activity, HeLa 229 cells expressed less Gb3-degradative a-galactosidase activity than did HeLa CCL2 cells.
We also used two strategies to directly increase cellular Gb3 content. We incubated resistant cells with DIG, a competitive inhibitor of lysosomal a-galactosidase A [20, 21] , to reduce the degradation rate of Gb3. As expected, this led to an increase in cellular content of Gb3 and Shiga toxin binding and a highly significant increase in sensitivity to toxin.
We next inserted Gb3 into resistant target cells using liposome fusion techniques. Waddell et al. [12] had previously reported that toxin-resistant mutant human Daudi lymphoma cells became sensitive when incubated with Gb3 liposomes, although liposome fusion itself was not assessed.
However, we were unable to confirm these results in HeLa cells, using either micellar Gb3 or liposomes prepared as described by Waddell et al. We therefore optimized the conditions with palmitate and polyethylene glycol and monitored fusion by fluorescence microscopy using carboxyfluorescein incorporated into the liposomes, a dye that fluoresces only when diluted into the cytoplasm after fusion [19] . Under these conditions, insertion of Gb3 but not Gb4 in liposomes resulted in an increase in both Shiga toxin binding and toxicity in HeLa T5 cells.
We also used PDMP, a specific competitive inhibitor of UDP-glucose:ceramide glucosyltransferase [22] , the first enzyme in the glycosylation pathway of globo-series glycosphingolipids such as Gb3 and Gb4, to reduce Gb3 synthesis.
PDMP treatment of BALB/c 3T3 cells alters cell morphology, increases lactate production, and enhances sugar uptake [28] . In Lewis murine lung carcinoma cells, PDMP reversibly impairs laminin-mediated attachment and migration [29] ; in B16 melanoma cells, expression of cell surface GM3
is reduced and the ability to bind adhesive proteins is lost [30] . In this study, incubation of toxin-sensitive Vero or HeLa 229 cells with PDMP reduced the content of Gb3 and its glycolipid precursors and resulted in high-level toxin resistance. However, using the optimized liposomal delivery system to add back Gb3 we could restore toxin binding and sensitivity, which demonstrates the essential role of Gb3 in the cellular response to Shiga toxin. Moreover, the ability to confer sensitivity to T5 cells or PDMP-treated Vero cells by fusion with Gb3 liposomes but not other glycolipids, such as lactosylceramide or Gb4, makes it unlikely that the resistance of these cells to the toxin is due to any mechanism other than that of receptor deficiency. Distinctive results were obtained with CHO-K1 cells, which normally lack Gb3 and do not increase Gb3 content in the presence of DIG and thus can be considered to be intrinsically resistant to Shiga toxin. When liposomal Gb3 was introduced into these cells by the identical fusion protocol used for HeLa and Vero cells, there was no change in the sensitivity of CHO cells, even though increased Shiga toxin binding was readily demonstrated. This raises the possibility that CHO cells may lack either the mechanism for translocation of Gb3-bound toxin from the cell surface to the cytoplasm or a second protein or glycoprotein receptor needed to interact with the uptake mechanism and/or direct the complex to the trans-Golgi region of the cell [31] and beyond to the endoplasmic reticulum [32] , where Shiga toxin exerts its biochemical action. The minimal toxicity observed in Gb3-deficient cells incubated with very high concentrations of Shiga toxin is probably due to non-receptor-based toxin uptake, as reported for receptor-negative diphtheria toxinresistant mouse L cells [33] . It is also remotely possible that CHO cell ribosomes are Although we have not directly tested the effect of Shiga toxin on isolated CHO cell ribosomes, these cells are sensitive to ricin, which has enzymatic specificity identical to Shiga toxin but a different route of uptake [25] . Our working hypothesis is that CHO cells lack a necessary postbinding translocation mechanism for Gb3-bound toxin. This hypothesis explains the results of Boyd et al. [11] , who found that some piglet tissues able to bind toxin in vivo are not damaged. The CHO cell with exogenously added Gb3 may provide the test system we need to investigate the nature of this mechanism.
